famotidine has been researched along with Agranulocytosis in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of agranulocytosis associated with initiation of famotidine." | 7.71 | Agranulocytosis associated with initiation of famotidine therapy. ( Bits, H; Clarfield, AM; Da'as, N; Darmon, D; Kleinman, Y; Marcus, EL, 2002) |
| "To report a case of agranulocytosis associated with initiation of famotidine." | 3.71 | Agranulocytosis associated with initiation of famotidine therapy. ( Bits, H; Clarfield, AM; Da'as, N; Darmon, D; Kleinman, Y; Marcus, EL, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marcus, EL | 1 |
| Clarfield, AM | 1 |
| Kleinman, Y | 1 |
| Bits, H | 1 |
| Darmon, D | 1 |
| Da'as, N | 1 |
1 other study available for famotidine and Agranulocytosis
| Article | Year |
|---|---|
Agranulocytosis associated with initiation of famotidine therapy.
Topics: Aged; Aged, 80 and over; Agranulocytosis; Blood Cell Count; Dermatitis, Exfoliative; Famotidine; Hum | 2002 |